URGENT: This Altcoin Opportunity Won’t Wait – Act Now

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

RLMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 18.00%

Insider Buying (Last 12 Months): $779,959.33

Insider Selling (Last 12 Months): $0.00

Relmada Therapeutics Insider Trading History Chart

Relmada Therapeutics Share Price & Price History

^$0.36

▲ +0.0102 (2.89%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Most People Are Dead Wrong.

From Brownstone Research | Ad

Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

Relmada Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2024	Maged Shenouda	CFO	Buy	24,120	$2.95	$71,154.00	88,335
9/11/2024	Sergio Traversa	CEO	Buy	51,407	$2.99	$153,706.93	384,024
9/9/2024	Charles J. Casamento	Director	Buy	13,000	$2.56	$33,280.00	13,000
9/9/2024	Maged Shenouda	CFO	Buy	8,194	$2.55	$20,894.70	43,097
9/9/2024	Sergio Traversa	CEO	Buy	55,579	$2.71	$150,619.09	299,603
1/31/2024	Maged Shenouda	CFO	Buy	6,875	$4.06	$27,912.50	34,903
1/31/2024	Sergio Traversa	CEO	Buy	27,460	$4.00	$109,840.00	244,024
1/30/2024	Chuck Ence	Insider	Buy	14,500	$3.87	$56,115.00	25,300
1/29/2024	Maged Shenouda	CFO	Buy	10,800	$3.65	$39,420.00	13,028
1/29/2024	Sergio Traversa	CEO	Buy	31,541	$3.71	$117,017.11	175,565
5/23/2023	Cedric O'gorman	Insider	Buy	10,000	$3.18	$31,800.00	10,121
12/8/2022	Sergio Traversa	CEO	Buy	55,250	$2.10	$116,025.00	144,024
6/30/2022	Sergio Traversa	CEO	Sell	16,012	$19.13	$306,309.56	88,774
4/4/2022	Paul Edward Kelly	Director	Sell	10,000	$30.04	$300,400.00	187,295

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

SEC Filings (Institutional Ownership Changes) for Relmada Therapeutics (NASDAQ:RLMD)

45.24% of Relmada Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Relmada Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	1,302,151	$4.36M	0.0%	+28.6%	4.316%
11/16/2024	Geode Capital Management LLC	304,502	$0.99M	0.0%	+16.9%	1.009%
11/15/2024	State Street Corp	99,235	$0.32M	0.0%	-6.3%	0.329%
11/15/2024	Jacobs Levy Equity Management Inc.	157,672	$0.51M	0.0%	+99.9%	0.523%
11/15/2024	HighTower Advisors LLC	10,000	$32K	0.0%	N/A	0.033%
11/14/2024	Vestal Point Capital LP	490,000	$1.59M	0.1%	-59.2%	1.624%
11/13/2024	FMR LLC	116,544	$0.38M	0.0%	+29.0%	0.386%
8/14/2024	Marshall Wace LLP	156,619	$0.47M	0.0%	-24.7%	0.519%
8/9/2024	Renaissance Technologies LLC	88,775	$0.27M	0.0%	+153.6%	0.294%
8/8/2024	American Century Companies Inc.	31,618	$95K	0.0%	+14.6%	0.105%
8/8/2024	AdvisorShares Investments LLC	90,028	$0.28M	0.0%	+28.5%	0.298%
8/6/2024	Acadian Asset Management LLC	1,193,333	$3.58M	0.0%	+1.0%	3.955%
7/20/2024	Parsons Capital Management Inc. RI	975,945	$2.93M	0.2%	+0.2%	3.235%
5/29/2024	Opaleye Management Inc.	759,000	$3.53M	0.8%	-13.5%	2.516%
5/16/2024	Jacobs Levy Equity Management Inc.	125,916	$0.59M	0.0%	-41.1%	0.417%
5/10/2024	Vanguard Group Inc.	1,256,705	$5.84M	0.0%	-4.1%	4.165%
5/9/2024	State Board of Administration of Florida Retirement System	15,100	$70K	0.0%	N/A	0.050%
5/7/2024	SG Americas Securities LLC	11,320	$53K	0.0%	N/A	0.038%
5/3/2024	GSA Capital Partners LLP	103,321	$0.48M	0.0%	-44.0%	0.342%
4/26/2024	Guild Investment Management Inc.	191,000	$0.89M	1.1%	-9.9%	0.633%
4/22/2024	Parsons Capital Management Inc. RI	973,520	$4.53M	0.3%	+2.5%	3.227%
2/15/2024	Opaleye Management Inc.	877,000	$3.63M	1.0%	+2,823.3%	2.914%
2/14/2024	ADAR1 Capital Management LLC	58,601	$0.24M	0.1%	N/A	0.195%
2/14/2024	Vestal Point Capital LP	115,000	$0.48M	0.1%	N/A	0.382%
2/14/2024	AdvisorShares Investments LLC	74,666	$0.31M	0.1%	-33.9%	0.248%
1/31/2024	Federated Hermes Inc.	99,839	$0.41M	0.0%	-12.6%	0.332%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	270,396	$1.12M	0.0%	+4.4%	0.898%
1/22/2024	Parsons Capital Management Inc. RI	949,841	$3.93M	0.3%	-2.5%	3.156%
1/12/2024	Guild Investment Management Inc.	212,100	$0.88M	1.4%	+3.3%	0.705%
12/6/2023	Citigroup Inc.	99,523	$0.30M	0.0%	-16.6%	0.331%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	87,153	$0.26M	0.0%	-16.6%	0.290%
11/13/2023	Acadian Asset Management LLC	1,172,723	$3.51M	0.0%	-4.0%	3.896%
11/13/2023	Silverarc Capital Management LLC	100,000	$0.30M	0.1%	N/A	0.332%
11/6/2023	Parsons Capital Management Inc. RI	974,082	$2.92M	0.2%	+11.5%	3.236%
11/6/2023	Guild Investment Management Inc.	205,300	$0.62M	1.0%	+84.0%	0.682%
10/27/2023	TD Asset Management Inc	25,000	$75K	0.0%	+100.0%	0.083%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	259,009	$0.78M	0.0%	-23.6%	0.860%
10/24/2023	Bank of New York Mellon Corp	36,719	$0.11M	0.0%	-53.8%	0.122%
10/24/2023	Stratos Wealth Partners LTD.	16,000	$48K	0.0%	N/A	0.053%
9/21/2023	Barclays PLC	145,999	$0.36M	0.0%	+884.0%	0.485%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	338,945	$0.83M	0.0%	+17.3%	1.126%
8/9/2023	AdvisorShares Investments LLC	112,898	$0.28M	0.1%	+8.4%	0.375%
8/7/2023	Tortoise Investment Management LLC	19,176	$47K	0.0%	+52.7%	0.064%
8/4/2023	Parsons Capital Management Inc. RI	873,312	$2.15M	0.2%	+20.9%	2.901%
8/3/2023	Barclays PLC	145,999	$0.36M	0.0%	+884.0%	0.485%
7/20/2023	Guild Investment Management Inc.	111,550	$0.27M	0.4%	+7.4%	0.371%
6/1/2023	Prelude Capital Management LLC	16,700	$38K	0.0%	N/A	0.055%
5/15/2023	RTW Investments LP	2,131,835	$4.82M	0.1%	+3.1%	7.083%
5/11/2023	Acadian Asset Management LLC	1,221,399	$2.76M	0.0%	+11.0%	4.058%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	109,959	$0.25M	0.0%	-7.3%	0.365%
5/9/2023	Tortoise Investment Management LLC	12,561	$28K	0.0%	+65.6%	0.042%
5/9/2023	AdvisorShares Investments LLC	104,140	$0.24M	0.1%	+28.0%	0.346%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	288,946	$0.65M	0.0%	+3.4%	0.960%
5/2/2023	Sargent Investment Group LLC	14,317	$34K	0.0%	N/A	0.048%
4/27/2023	Tiedemann Advisors LLC	30,215	$68K	0.0%	+49.5%	0.100%
4/18/2023	Guild Investment Management Inc.	103,900	$0.24M	0.4%	N/A	0.345%
4/17/2023	Parsons Capital Management Inc. RI	722,166	$1.63M	0.1%	+45.5%	2.399%
2/15/2023	Tang Capital Management LLC	100,000	$0.35M	0.1%	-75.0%	0.332%
2/13/2023	The Manufacturers Life Insurance Company	25,037	$89K	0.0%	-17.7%	0.083%
2/13/2023	GSA Capital Partners LLP	122,590	$0.43M	0.1%	N/A	0.407%
2/10/2023	AXQ Capital LP	12,483	$44K	0.0%	N/A	0.041%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	118,651	$0.41M	0.0%	+245.6%	0.394%
2/10/2023	HRT Financial LP	158,320	$0.55M	0.0%	N/A	0.526%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	279,415	$0.98M	0.0%	+287.9%	0.928%
2/9/2023	Chicago Partners Investment Group LLC	14,310	$57K	0.0%	N/A	0.048%
2/9/2023	Cowen AND Company LLC	64,011	$0.22M	0.0%	-70.4%	0.213%
2/8/2023	Tiedemann Advisors LLC	20,215	$71K	0.0%	+97.9%	0.067%
2/7/2023	State Board of Administration of Florida Retirement System	15,100	$53K	0.0%	-32.4%	0.050%
2/6/2023	Los Angeles Capital Management LLC	12,651	$44K	0.0%	+109.1%	0.042%
1/31/2023	apricus wealth LLC	77,329	$0.27M	0.2%	-28.0%	0.257%
1/30/2023	New York State Common Retirement Fund	12,359	$43K	0.0%	-63.2%	0.041%
1/27/2023	Exchange Traded Concepts LLC	11,981	$42K	0.0%	+274.3%	0.040%
1/18/2023	Exchange Traded Concepts LLC	11,981	$42K	0.0%	+274.3%	0.040%
11/23/2022	Invst LLC	6,753	$0.23M	0.0%	N/A	0.022%
11/18/2022	Spotlight Asset Group Inc.	20,000	$0.14M	0.1%	N/A	0.066%
11/15/2022	Stokes Family Office LLC	5,935	$0.22M	0.0%	N/A	0.020%
11/15/2022	Perceptive Advisors LLC	2,383,478	$88.24M	2.6%	+1,864.1%	7.919%
11/15/2022	Endurant Capital Management LP	14,145	$0.52M	0.2%	N/A	0.047%
11/15/2022	Ensign Peak Advisors Inc	41,530	$1.54M	0.0%	+11,436.1%	0.138%
11/15/2022	BVF Inc. IL	2,078,220	$76.94M	3.2%	+25.3%	6.904%
11/15/2022	Bellevue Group AG	53,187	$1.97M	0.0%	+52.0%	0.177%
11/14/2022	RTW Investments LP	2,644,475	$97.90M	2.3%	+0.3%	8.797%
11/14/2022	Vivo Capital LLC	713,238	$26.40M	2.9%	+1.0%	2.373%
11/14/2022	Cubist Systematic Strategies LLC	35,125	$1.30M	0.0%	-15.0%	0.117%
11/14/2022	VR Adviser LLC	1,518,056	$56.20M	8.3%	-33.1%	5.050%
11/10/2022	Nan Fung Group Holdings Ltd	5,642	$0.21M	0.1%	N/A	0.019%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	34,336	$1.27M	0.0%	N/A	0.114%
11/10/2022	ExodusPoint Capital Management LP	29,786	$1.10M	0.0%	+63.2%	0.099%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,321	$0.12M	0.0%	+1,638.7%	0.011%
11/8/2022	IMC Chicago LLC	26,350	$0.98M	0.0%	N/A	0.088%
11/8/2022	AlphaCentric Advisors LLC	5,500	$0.20M	0.2%	N/A	0.018%
11/8/2022	State Board of Administration of Florida Retirement System	22,350	$0.83M	0.0%	-12.7%	0.074%
11/8/2022	International Biotechnology Trust PLC	10,000	$0.37M	0.1%	+5,163.2%	0.033%
11/8/2022	New York State Common Retirement Fund	33,596	$1.24M	0.0%	+66.5%	0.112%
11/7/2022	Arizona State Retirement System	6,112	$0.23M	0.0%	N/A	0.020%
11/7/2022	ProShare Advisors LLC	5,537	$0.21M	0.0%	N/A	0.018%
11/3/2022	Creative Planning	6,509	$0.24M	0.0%	N/A	0.022%
11/3/2022	Barclays PLC	7,101	$0.26M	0.0%	-57.5%	0.024%
11/2/2022	Los Angeles Capital Management LLC	6,051	$0.22M	0.0%	N/A	0.020%
10/31/2022	Concorde Asset Management LLC	11,700	$0.43M	0.5%	N/A	0.039%

Data available starting January 2016

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.

Today's Range

Now: $0.36

$0.34

$0.38

50 Day Range

MA: $2.52

$0.35

$3.64

52 Week Range

Now: $0.36

$0.34

$7.22

Volume

424,888 shs

Average Volume

341,736 shs

Market Capitalization

$10.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Relmada Therapeutics?: Relmada Therapeutics' top insider shareholders include:
Sergio Traversa (CEO)
Maged Shenouda (CFO)
Chuck Ence (Insider)
Charles J Casamento (Director)
Cedric O'gorman (Insider)
Learn More about top insider investors at Relmada Therapeutics.
Who are the major institutional investors of Relmada Therapeutics?: Relmada Therapeutics' top institutional shareholders include:
Franklin Resources Inc. — 4.32%
Vestal Point Capital LP — 1.62%
Geode Capital Management LLC — 1.01%
Jacobs Levy Equity Management Inc. — 0.52%
FMR LLC — 0.39%
State Street Corp — 0.33%
Learn More about top institutional investors of Relmada Therapeutics stock.
Which major investors are selling Relmada Therapeutics stock?: Within the previous quarter, RLMD stock was sold by these institutional investors:
Vestal Point Capital LP
State Street Corp
Which major investors are buying Relmada Therapeutics stock?: Within the last quarter, RLMD stock was purchased by institutional investors including:
Franklin Resources Inc.
Jacobs Levy Equity Management Inc.
Geode Capital Management LLC
FMR LLC
HighTower Advisors LLC
During the last year, these company insiders have bought Relmada Therapeutics stock:
Sergio Traversa (CEO)
Maged Shenouda (CFO)
Chuck Ence (Insider)
Charles J Casamento (Director)
Cedric O'gorman (Insider)
Learn More investors buying Relmada Therapeutics stock.